开心人品牌怎么样 申请店铺

外推网助力开心人品牌出海！将品牌入驻外推网，定制开心人品牌推广信息，可以显著提高开心人产品曝光，简直是跨境电商爆单神器！目前仅需1000元/年哦~

开心人大药房连锁有限公司在2010年春正式运营上线，运营总部设在北京，在上海和南昌设有运营分部，现有员工一百人。公司团队人员主要由来自各大互联网公司和拥有良好零售经验的人士组成。

我们立志于将我们的电子商务平台-----开心人网上药店打造成中国网络家庭健康商品的第一提供商，现在网站上主营的商品数为一万左右，主要有药品、化妆品、保健品、医疗器械等，我们也在不断扩充商品数。在开心人在线运营的半年时间中，我们已经在发展速度上创造了非常可喜的成绩，在规模上也已经进入行业的前列。

我们希望在创造中国电子商务下一个奇迹的路上，在我们成长的路上有您的加入，我们为您提供良好的工作氛围和很好的成长平台！期待您的加入！
开心人集团规模及发展状况

开心人集团自2002年8月31日开业以来，一直秉承着“品牌创造价值，责任铸就辉煌”的创业理念；“药道即人道、药品即人品”、“卖良心药，做开心人”、“用专业筛选好药、以实惠感恩为民”、“让更多人用得起更多好药”的价值理念；“关注民众、关心民生、降低药价、惠及百姓”的社会责任意识，始终如一地以“药好价低”的社会承诺和经营准则来满足广大群众对医药的消费需求，为改善民生，推进和谐社会建设积极努力。2007年开心人以13.8亿的总销售额名列中国医药连锁前十强，国内连锁店达121家。2010年初花旗银行控股的日本日兴集团国际战略投资（下称"日兴集团"）已于近日向开心人注入1亿元人民币，而未来2年内，日兴集团的注资将累计达到3000万~5000万美元。1亿元人民币到位后，开心人将会在今年展开收购整合以及开直营店两大行动，大规模在全国市场布局。将在全国范围内收购部分二、三线城市的药店。目前，其已经启动在福建厦门、新疆、山西、江苏等地的并购计划，目标将主要锁定当地小规模连锁药店，采用全资购买或者控股的方式。除了扩张门店数量外，开心人已经将上市列为其近期目标之一。今年南昌市已把开心人列为重点扶持的拟上市企业，可享受为拟上市企业提供的各种优惠政策。此次日兴集团的投资只是开心人的第一笔融资，而未来3~5年内，开心人还将陆续争取其他企业的风投。八年多来，开心人积累了先进的药店管理经验和大批的药店精英人才。不管是资金、技术、人才、规模，还是管理、经验，开心人的实力都比较雄厚、优势也很明显。

Kaixin pharmacy chain Co., Ltd. was officially launched in the spring of 2010. Its headquarter is located in Beijing. It has operation branches in Shanghai and Nanchang, with 100 employees. The team members of the company are mainly from major Internet companies and people with good retail experience. We are determined to build our e-commerce platform, Kaixinren online drugstore, into the first provider of online family health products in China. Now the number of products on the website is about 10000, mainly including drugs, cosmetics, health products, medical devices, etc. we are also expanding the number of products. In the half year of Kaixin people's online operation, we have made great achievements in the development speed and entered the forefront of the industry in terms of scale. We hope that on the way to create the next miracle of China's e-commerce, you will join us in our growth. We will provide you with a good working atmosphere and a good growth platform! Looking forward to your joining! The scale and development of Kaixinren group since its opening on August 31, 2002, Kaixinren group has been adhering to the entrepreneurial concept of "brand creates value, responsibility creates brilliance;" medicine is humanity, medicine is character "," selling conscience medicine, being Kaixinren "," selecting good medicine with specialty, giving thanks for benefits for the people "and" making more people can use more good medicine " The social responsibility consciousness of "paying attention to the people, caring about the people's livelihood, reducing the drug price and benefiting the people" consistently meets the people's consumption demand for medicine with the social commitment of "good medicine and low price" and the business principle, and makes positive efforts to improve the people's livelihood and promote the construction of a harmonious society. In 2007, Kaixinren ranked among the top ten Chinese pharmaceutical chains with a total sales volume of 1.38 billion, with 121 domestic chains. At the beginning of 2010, Nikko Group International Strategic Investment (hereinafter referred to as "Nikko group") controlled by Citibank has recently injected 100 million yuan into Kaixin people, and in the next two years, Nikko group's investment will reach 30-50 million US dollars in total. After 100 million yuan is in place, Kaixinren will launch two major actions this year, namely acquisition and integration and opening direct stores, to make a large-scale distribution in the national market. Some drugstores in second and third tier cities will be purchased nationwide. At present, it has launched M & A plans in Xiamen, Xinjiang, Shanxi, Jiangsu and other places in Fujian Province, with the goal of mainly targeting local small-scale chain drugstores and adopting wholly-owned purchase or holding. In addition to expanding the number of stores, Kaixin has listed listing as one of its short-term goals. This year, Nanchang City has listed Kaixin people as the key supporting enterprises to be listed, and can enjoy various preferential policies for the enterprises to be listed. The investment of Rixing group is only the first financing of Kaixin group. In the next 3-5 years, Kaixin group will strive for venture capital of other enterprises. Over the past eight years, Kaixin people have accumulated advanced pharmacy management experience and a large number of pharmacy elites. Whether it's capital, technology, talent, scale, management or experience, Kaixin people have strong strength and obvious advantages.

本文链接： https://brand.waitui.com/314dd8e28.html 联系电话：请联系客服添加 联系邮箱：请联系客服添加